Picture Kentro Design Corporate and Web Design Berlin 600x60px
Document › Details

bioMérieux S.A.. (10/18/17). "Press Release: bioMérieux – Business Review for the Nine Months ended September 30, 2017".

Organisation Organisation bioMérieux S.A. (Euronext: BIM)
  Group Mérieux (Group)
Products Product molecular diagnostics
  Product 2 clinical diagnostics
Person Person Mérieux, Alexandre (Mérieux 201712– CEO at bioMérieux before Deputy CEO before VP Industrial Microbiology)

> Solid growth in sales, up 10.7% at constant exchange rates and scope of consolidation
€1,674 million in sales
Up 10.8% as reported

> In microbiology, growth accelerated to nearly 8%

> Contribution from all regions to the Group's strong sales dynamic, particularly the Asia-Pacific region, with sales in China and India up almost 15%

Alexandre Mérieux, Chief Executive Officer, said: "Third-quarter growth for bioMérieux once again reflected the strong sales dynamic we have enjoyed for several quarters. Robust growth for the microbiology lines and sustained growth for the molecular biology lines pushed sales up by more than 10% for the first nine months of the year, placing us firmly on track to achieving our annual targets."

Download [Full Release at ]

Record changed: 2017-10-30


Picture [LSUS] – The Business Web Portal 600x60px

More documents for Mérieux (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BioPharm America 2019 Boston September 600x60px

» top